跳至主要内容
临床试验/NCT06541990
NCT06541990招募中不适用

HARMONY: A Psychoeducational Intervention to Reduce Psychological Distress and Improve Quality of Life for Patients With Hepatocellular Carcinoma

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年10月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
2
主要终点
Feasibility: study enrollment rate

研究概览

简要总结

This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

详细描述

There are two parts of this study. Study Part 1 is an open pilot study to refine HARMONY prior to larger-scale testing in a randomized controlled trial (RCT) setting. Study Part 1 is purely descriptive, as the investigators will use the data to refine HARMONY before proceeding to Study Part 2.

Study Part 2 is a pilot RCT to assess the feasibility and acceptability of conducting a randomized trial of HARMONY versus enhanced usual care. Participants will complete a baseline survey and then be randomized to HARMONY versus enhanced usual care (a supportive care resource guide). This record reflects the clinical trial component (Study Part 2), as feasibility and acceptability outcomes will be collected for this phase only.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • New diagnosis of HCC within the last six months
  • Ability to complete study procedures English

排除标准

  • Incidentally diagnosed with HCC after liver transplantation
  • Significant uncontrolled hepatic encephalopathy, cognitive impairment, or psychiatric disorder which will interfere with study participation
  • Patients near the end of life for whom hospice is recommended

结局指标

主要结局

Feasibility: study enrollment rate

时间窗: 10 weeks

≥40% enrollment among consecutive eligible patients

次要结局

  • Feasibility: intervention completion rate(10 weeks)
  • Acceptability(10 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kelsey S. Lau-Min, MD

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验